Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Erlotinib Hydrochloride × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Pancreatic Neoplasms 6 Neoplasms 5 Lung Neoplasms 4 Head and Neck Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Melanoma 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Diseases 1 Parotid Neoplasms 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms, Basal Cell 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Liver Cirrhosis 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Cyclophosphamide 5 Radiotherapy 3 Automobiles 3 fludarabine 2 Vincristine 2 Temozolomide 2 Eflornithine 2 Cisplatin 2 omburtamab I-131 1 ibrutinib 1 gallium Ga 68 dotatate 1 belzutifan 1 Zoledronic Acid 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Pemetrexed 1 ONC206 1 Nivolumab 1 Maintenance Chemotherapy 1 Lomustine 1 Infusions, Intravenous 1 Induction Chemotherapy 1 HhAntag691 1 Gemcitabine 1 Exercise 1 Etoposide 1 Drug Therapy 1 Diploidy 1 Craniospinal Irradiation 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡